Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» aducanumab
aducanumab
Biogen and the desperation of a need for Alzheimer's drugs
Fierce Biotech
Fri, 12/20/19 - 08:13 pm
Biogen
FDA
Alzheimer's disease
aducanumab
Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's
Fierce Biotech
Fri, 12/13/19 - 12:26 pm
Biogen
Alzheimer's disease
aducanumab
progressive supranuclear palsy
gosuranemab
clinical trials
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results
Xconomy
Thu, 12/5/19 - 11:35 pm
Biogen
Alzheimer's disease
aducanumab
Worldwide Clinical Trials
The clearest picture of Biogen's Alzheimer's drug is still fuzzy
Biopharma Dive
Thu, 12/5/19 - 11:34 pm
Biogen
Alzheimer's disease
clinical trials
aducanumab
New Biogen data showed no major safety issues for its Alzheimer's drug
Reuters
Thu, 12/5/19 - 12:16 pm
Biogen
safety
Alzheimer's disease
aducanumab
clinical trials
What to watch as Biogen presents its all-important Alzheimer's data
Biopharma Dive
Wed, 12/4/19 - 11:11 pm
Biogen
clinical trials
Alzheimer's disease
aducanumab
Biogen’s stock could fall 10% on new Alzheimer’s drug data this week, top analyst says
CNBC
Tue, 12/3/19 - 10:18 pm
Biogen
Alzheimer's disease
aducanumab
Analyst: Biogen's aducanumab is not getting approved absent a deus ex machina
Fierce Biotech
Mon, 12/2/19 - 10:44 am
Biogen
aducanumab
FDA
Alzheimer's disease
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Biogen
MS
multiple sclerois
Alzheimer's disease
Tecfidera
aducanumab
Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug
Stat
Thu, 11/21/19 - 11:20 pm
Biogen
aducanumab
FDA
Alzheimer's disease
Here's Why Biogen Stock Shot Up 28% in October
Motley Fool
Sun, 11/10/19 - 07:51 pm
Biogen
Alzheimer's disease
aducanumab
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Yahoo/Guru Focus
Mon, 10/28/19 - 11:09 pm
Biogen
Alzheimer's disease
aducanumab
clinical trials
drug development
2 Biotech Stocks That Soared Last Week
Motley Fool
Mon, 10/28/19 - 10:34 am
Biogen
Arvinas
aducanumab
protein degradation
ARV-110
More Details Emerge on Biogen’s Alzheimer’s Comeback
BioSpace
Mon, 10/28/19 - 10:31 am
Biogen
Alzheimer's disease
aducanumab
An Alzheimer’s patient on what was lost when Biogen shut down its trial, and what may be gained again
Stat
Fri, 10/25/19 - 10:40 am
Biogen
patients
Alzheimer's disease
aducanumab
clinical trials
Biogen's Stock Could More Than Quadruple in Value in 5 Years
Motley Fool
Wed, 10/23/19 - 10:08 am
Biogen
biotech stocks
aducanumab
Alzheimer's disease
7 questions on Biogen's revival of a failed Alzheimer's drug
Biopharma Dive
Tue, 10/22/19 - 11:07 pm
Biogen
aducanumab
Alzheimer's disease
Alzheimer’s patients in Biogen trial, jolted by revival of drug, press for access once again
Stat
Tue, 10/22/19 - 10:56 pm
Biogen
Alzheimer's disease
FDA
aducanumab
Biogen resurrects aducanumab, arguing expanded data set supports FDA filing in Alzheimer's
Fierce Biotech
Tue, 10/22/19 - 11:05 am
Biogen
Alzheimer's disease
aducanumab
FDA
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Fierce Biotech
Fri, 09/13/19 - 10:45 am
Biogen
Eisai
Alzheimer's disease
BACE inhibitors
elenbecestat
aducanumab
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »